Dr. Agarwal’s Eye Hospital Limited is a leading eye care services chain primarily operating in Tamil Nadu, India.
Founded in 1957 in Chennai by Dr. Tahira Agarwal and Dr. Jaiveer Agarwal, the company operates 63 facilities as of March 2025.
The company treats over 588,000 patients annually and performs approximately 62,000 surgeries, with 80.7% being cataract procedures.
Core services include ophthalmic surgeries (cataract, corneal transplants, retinal procedures), diagnostics, and preventive eye care.
Operates under an asset-light hub-and-spoke model, with leased facilities enabling rapid expansion into urban and underserved regions.
Focus on clinical innovation, including techniques like Glued Intraocular Lens (IOL) and Pre-Descemet’s Endothelial Keratoplasty (PDEK).
Growth thesis
Dr Agarwals Eye Hospital Ltd delivers specialized ophthalmic care through diagnostic, surgical, and outpatient services. Revenue is driven by inpatient treatments, outpatient procedures, and diagnostic solutions. Growth depends on regional healthcare demand, demographic trends like aging populations, and operational efficiency improvements. Over 2-3 years, the business may benefit from expanding healthcare accessibility and rising eye care needs, though execution risks around service quality and regulatory compliance remain key challenges. Limited recent guidance and catalyst data reduce clarity on specific growth timelines or margin expansion potential.
RS rating: 59Stage: Stage 2
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Dr. Agarwal's Eye Hospital Limited and 4,900+ companies.